Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
Article in Molecular Biotechnology (June 2024)
The most recent citing publications are shown below. View all 72 publications that cite this research output on Dimensions.
Article in Molecular Biotechnology (June 2024)
Article in Developmental Cell (June 2024)
Article in Cancer Immunology, Immunotherapy (June 2024)